NeuroOne Medical Technologies Corporation (NMTC) — Dilution Risk Analysis

Current Snapshot

NeuroOne Medical Technologies Corporation (NMTC) has a DilutionWatch score of 59/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
9,105,763 Source
Public Float
7,822,882 Source
Float as % of Outstanding
85.9%

Dilution Risk Score

Score: 59/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 9, 8-K 1.

FormFiledAccession
4 2026-04-07 0001656026-26-000003
4 2026-04-07 0001215243-26-000004
4 2026-04-07 0001296853-26-000001
4 2026-04-07 0002103204-26-000005
8-K 2026-04-03 0001213900-26-039992
4 2026-04-01 0001540354-26-000005
4 2026-04-01 0001772652-26-000005
4 2026-04-01 0001709738-26-000009
4 2026-03-16 0001709738-26-000008
4 2026-03-12 0001709738-26-000007

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 3 months Source
Three-year share count growth 90.34% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 59/10) Source
Cash Runway
3 months Source
Share Count Growth (3-Year)
90.34% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.